TABLE 2.
Demographic characteristics, clinical and laboratory findings at hospital admission, and end results for the 95 patients included in the study
| Characteristic | Value for groupa
|
|
|---|---|---|
| All patients | N. meningitidis meningitisb | |
| Demographic | ||
| Residence | ||
| North Gondar Zone | 23/95 (24) | 19/71 (27) |
| Sidama and Gedio Zones | 72/95 (76) | 52/71 (73) |
| Yr | ||
| 2002 | 51/95 (54) | 38/71 (54) |
| 2003 | 44/95 (46) | 33/71 (46) |
| Age (yr) | ||
| 0.5-<2 | 7/93 (8) | 3/70 (4) |
| 2-<6 | 12/93 (13) | 10/70 (14) |
| 6-<15 | 29/93 (31) | 25/70 (36) |
| 15-<20 | 15/93 (16) | 12/70 (17) |
| ≥20 | 30/93 (32) | 20/70 (29) |
| Alld | 16.0 (13.6-18.3), 14 | 15.0 (12.6-17.5), 14 |
| Sex | ||
| Male | 54/93 (58) | 38/70 (54) |
| Female | 39/93 (42) | 32/70 (46) |
| Preadmission history | ||
| Antibiotics given before admission | 10/90 (11) | 6/67 (9) |
| Previously vaccinated with serogroup A polysaccharide vaccine | 15/90 (17) | 11/67 (16) |
| Days of illness from first symptoms to examination at hospital (n = 92; range, 0-9)d | 2.9 (2.6-3.3), 3 | 2.9 (2.5-3.3), 2 |
| Clinical and laboratory findings at hospital admission | ||
| Nuchal rigidity | 89/89 (100) | 66/66 (100) |
| Back rigidity | 34/58 (59) | 23/41 (56) |
| Ecchymoses | 7/71 (10) | 5/56 (9) |
| Petechiae, ≥10 | 15/39 (38) | 11/28 (39) |
| Seizures | 12/91 (13) | 8/68 (12) |
| Shock | 4/90 (4) | 2/67 (3) |
| Coma | 14/91 (15) | 7/68 (10) |
| End resultc | ||
| Death | 11/95 (12) | 3/71 (4) |
| Sequelae | 3/95 (3) | 2/71 (3) |
| Days of stay at hospital (n = 47; range, 0-15)d | 6.5 (5.5-7.4), 7 | 6.3 (5.2-7.3), 7 |
a
Except where otherwise noted, values are no. of patients with characteristic/total no. of patients for whom data were available (% of reported cases).
b
Cases of N. meningitidis meningitis confirmed by either culture or PCR of CSF (n=71).
c
As observed during hospital admission.
d
Values are means (95% CIs), medians.